These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20207642)

  • 21. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.
    Grieco A; Pompili M; Caminiti G; Miele L; Covino M; Alfei B; Rapaccini GL; Gasbarrini G
    Gut; 2005 Mar; 54(3):411-8. PubMed ID: 15710992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
    Trevisani F; Magini G; Santi V; Morselli-Labate AM; Cantarini MC; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
    Am J Gastroenterol; 2007 May; 102(5):1022-31. PubMed ID: 17313497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of combinated transcatheter hepatic artery chemoembolization and factors affecting the prognosis in patients with primary hepatic carcinoma].
    Li CX; Zhang Y; Gao L
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):942-5. PubMed ID: 17533749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
    Farinati F; Sergio A; Giacomin A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
    Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1212-8. PubMed ID: 19465859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM; Qin H; Wang CB; Fang XH; Ma QY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
    J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
    J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey.
    Huo T; Huang YH; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1301-8. PubMed ID: 15191512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
    Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current treatment strategy for hepatocellular carcinoma.
    Ng KK; Poon RT
    Saudi Med J; 2007 Sep; 28(9):1330-8. PubMed ID: 17768455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
    Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization.
    Seo DD; Lee HC; Jang MK; Min HJ; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ; Ko GY; Lee YJ; Lee SG
    Ann Surg Oncol; 2007 Dec; 14(12):3501-9. PubMed ID: 17899289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management.
    Poon RT; Fan ST; Lo CM; Liu CL; Ngan H; Ng IO; Wong J
    Am J Gastroenterol; 1999 Sep; 94(9):2460-6. PubMed ID: 10484009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Peng ZW; Chen MS; Liang HH; Gao HJ; Zhang YJ; Li JQ; Zhang YQ; Lau WY
    Eur J Surg Oncol; 2010 Mar; 36(3):257-63. PubMed ID: 19643561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver resection improves the survival of patients with multiple hepatocellular carcinomas.
    Ho MC; Huang GT; Tsang YM; Lee PH; Chen DS; Sheu JC; Chen CH
    Ann Surg Oncol; 2009 Apr; 16(4):848-55. PubMed ID: 19159983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection.
    Pandey D; Lee KH; Wai CT; Wagholikar G; Tan KC
    Ann Surg Oncol; 2007 Oct; 14(10):2817-23. PubMed ID: 17690940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.